GreenLight Biosciences (GRNAW)
0.02
-0.00 (-0.99%)
At close: Jul 21, 2023, 4:10 PM
Company Description
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications.
Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops.
The company was founded in 2008 and is headquartered in Medford, Massachusetts.
GreenLight Biosciences
| Country | United States |
| IPO Date | n/a |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 280 |
| CEO | n/a |
Contact Details
Address: 200 Boston Avenue Medford, Massachusetts United States | |
| Website | https://greenlightbiosciences.com |
Stock Details
| Ticker Symbol | GRNAW |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001822691 |
| CUSIP Number | 39536G113 |
| ISIN Number | n/a |
| Employer ID | 85-1914700 |
| SIC Code | 2836 |
Key Executives
No executives data available.Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 11, 2023 | 15-12G | Filing |
| Jul 28, 2023 | SC 13D/A | [Amend] Filing |
| Jul 28, 2023 | SC 13D/A | [Amend] Filing |
| Jul 28, 2023 | 8-K/A | [Amend] Current Report |
| Jul 27, 2023 | SC 13D/A | [Amend] Filing |
| Jul 27, 2023 | 4 | Filing |
| Jul 27, 2023 | 3 | Filing |
| Jul 27, 2023 | 4 | Filing |
| Jul 27, 2023 | 4 | Filing |
| Jul 27, 2023 | 4 | Filing |